Lexpos News

/Lexpos News

MHRA Class 4 Medicines Defect Information: Ibuprofen 400mg Tablets, Paracetamol 500mg Tablets (Caplets) (Flamingo Pharma UK Ltd)

Class 4 Medicines Defect Information: Ibuprofen 400mg Tablets, Paracetamol 500mg Tablets (Caplets) (Flamingo Pharma UK Ltd) Drug alert number: EL (22)A/43 Date issued: 12 October 2022 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Ibuprofen 400mg Tablets, PL 43461/0005 Batch Number Expiry Date Pack Size [...]

The post MHRA Class 4 Medicines Defect Information: Ibuprofen 400mg Tablets, Paracetamol 500mg Tablets (Caplets) (Flamingo Pharma UK Ltd) appeared first on PSNC Website.

By |October 12th, 2022|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Ibuprofen 400mg Tablets, Paracetamol 500mg Tablets (Caplets) (Flamingo Pharma UK Ltd)

MHRA Class 2 Medicines Recall: Amiodarone Hydrochloride 50 mg/ml Concentrate for Solution for Injection/Infusion

Drug alert number: EL(22)A/42 Date issued: 10 October 2022 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Amiodarone Hydrochloride 50 mg/ml Concentrate for Solution for Injection/Infusion – Hameln pharma ltd – PL 25215/0026 Batch Number Expiry Date Pack Size First Distributed 210505 03/2024 10 x 3 ml [...]

The post MHRA Class 2 Medicines Recall: Amiodarone Hydrochloride 50 mg/ml Concentrate for Solution for Injection/Infusion appeared first on PSNC Website.

By |October 12th, 2022|Lexpos News|Comments Off on MHRA Class 2 Medicines Recall: Amiodarone Hydrochloride 50 mg/ml Concentrate for Solution for Injection/Infusion

PQS: NHS England 2022/23 guidance published

NHS England (NHSE) has published guidance on the 2022/23 Pharmacy Quality Scheme (PQS). The guidance document provides information on how community pharmacy contractors can meet the gateway criteria and domain requirements. Contractors are encouraged to read the NHSE guidance in order to understand the PQS requirements. Read the NHSE PQS 2022/23 guidance Further information on [...]

The post PQS: NHS England 2022/23 guidance published appeared first on PSNC Website.

By |October 11th, 2022|Lexpos News|Comments Off on PQS: NHS England 2022/23 guidance published

Update on pharmacy IT workstreams published

Following its meeting on the 21st of September 2022, the Community Pharmacy IT Group (CP ITG) has published its quarterly Pharmacy IT roundup for Autumn 2022. The roundup includes updates on: Current prioritisation by NHS IT policy makers and the CP ITG The progress made concerning pharmacy IT standards Upcoming events which pharmacy team members [...]

The post Update on pharmacy IT workstreams published appeared first on PSNC Website.

By |October 10th, 2022|Lexpos News|Comments Off on Update on pharmacy IT workstreams published

PQS 2022/23 starts today – are you ready to start working towards the Respiratory domain?

Community pharmacy contractors are reminded that if they intend to meet the Respiratory domain of the Pharmacy Quality Scheme (PQS) 2022/23, they must start working towards the following quality criteria from today (10th October 2022):  Inhaler waste management;  Use of a spacer in patients aged 5-15 years; and  Personalised asthma action plans.   Most pharmacy teams will be [...]

The post PQS 2022/23 starts today – are you ready to start working towards the Respiratory domain? appeared first on PSNC Website.

By |October 10th, 2022|Lexpos News|Comments Off on PQS 2022/23 starts today – are you ready to start working towards the Respiratory domain?